Physician
Rock-A-Bye Pediatrics PC
Rock-A-Bye Pediatrics PC was paid $2.19M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoROCK-A-BYE PEDIATRICS PC
MANASSAS, VA 20110
MANASSAS, VA 20110
33aNPI1477741650assigned 10/12/2007
33bProvider typePediatrics Physician
28Total paid$2.19M
24GClaims76,020
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#88 of 817
Median peer was paid$29K
This provider vs. median75×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,189 | $112K | |
| 2019 | 6,989 | $161K | |
| 2020 | 7,364 | $199K | |
| 2021 | 10,712 | $290K | |
| 2022 | 14,797 | $429K | |
| 2023 | 16,303 | $507K | |
| 2024incomplete | 15,666 | $490K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 9,885 | 8,412 | $557K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 5,618 | 4,886 | $472K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.7% | 2,547 | 2,424 | $189K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.3% | 2,195 | 2,096 | $161K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.4% | 2,113 | 1,920 | $140K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.7% | 3,635 | 3,257 | $103K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.4% | 1,172 | 1,129 | $96K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.3% | 7,525 | 3,471 | $94K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.7% | 4,837 | 4,161 | $59K |
| 90670 | 1.5% | 1,416 | 1,327 | $33K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.4% | 3,802 | 3,284 | $31K |
| 90677 | 1.3% | 409 | 392 | $29K |
53 more codes
| 90686 | <1% | 2,021 | $21K | |
| 92551 | <1% | 2,027 | $19K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 443 | $15K |
| 90651 | <1% | 558 | $15K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 114 | $13K |
| 90674 | <1% | 935 | $13K | |
| 90633 | <1% | 999 | $12K | |
| 90697 | <1% | 284 | $12K | |
| 96127 | <1% | 2,280 | $11K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 7,977 | $9K |
| 90681 | <1% | 487 | $9K | |
| 90734 | <1% | 382 | $8K | |
| 0071A | <1% | 162 | $6K | |
| 0072A | <1% | 152 | $6K | |
| 90461 | <1% | 3,213 | $6K | |
| 99173 | <1% | 2,276 | $5K | |
| 90648 | <1% | 521 | $5K | |
| 90698 | <1% | 301 | $5K | |
| 90723 | <1% | 330 | $5K | |
| 90710 | <1% | 167 | $4K | |
| 0001A | <1% | 96 | $3K | |
| 90661 | <1% | 282 | $3K | |
| 99401 | <1% | 216 | $3K | |
| 0002A | <1% | 68 | $3K | |
| 99381 | <1% | 26 | $2K | |
| 90696 | <1% | 106 | $1K | |
| 90715 | <1% | 110 | $1K | |
| 99000 | <1% | 1,667 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $986.40 |
| 90685 | <1% | 91 | $909.38 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 128 | $772.16 |
| 85018 | <1% | 337 | $747.00 | |
| 83655 | <1% | 65 | $743.30 | |
| 99051 | <1% | 395 | $653.38 | |
| 90716 | <1% | 47 | $648.47 | |
| 90707 | <1% | 41 | $527.31 | |
| 99050 | <1% | 39 | $452.51 | |
| 96160 | <1% | 184 | $395.68 | |
| 92552 | <1% | 13 | $346.45 | |
| 81001 | <1% | 147 | $308.78 | |
| 97802 | <1% | 65 | $306.40 | |
| 96161 | <1% | 60 | $93.40 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 91 | $90.90 |
| 94760 | <1% | 116 | $74.59 | |
| 36416 | <1% | 127 | $43.99 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 12 | $13.68 |
| 87081 | <1% | 24 | $6.63 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 38 | $5.22 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 33 | $4.74 |
| 91307 | <1% | 356 | $2.42 | |
| 91300 | <1% | 220 | $0.14 | |
| 91308 | <1% | 12 | $0.10 | |
| 90480 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHOWHAN, ANIKA (PHYSICIAN)